We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.69B
AUM Growth
-$542M
Cap. Flow
-$781M
Cap. Flow %
-21.18%
Top 10 Hldgs %
56.86%
Holding
480
New
156
Increased
61
Reduced
86
Closed
113

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$207M
2
BPMC
Blueprint Medicines
BPMC
+$176M
3
WBA
Walgreens Boots Alliance
WBA
+$167M
4
DNB
Dun & Bradstreet
DNB
+$122M
5
INFA
Informatica
INFA
+$93.8M

Top Sells

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$408M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$408M
3
HES
Hess
HES
+$251M
4
BECN
Beacon Roofing Supply, Inc.
BECN
+$195M
5
BERY
Berry Global Group, Inc.
BERY
+$137M

Sector Composition

Rank Sector Weight
1 Healthcare 19.77%
2 Technology 14.28%
3 Consumer Staples 10.98%
4 Energy 9.87%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
151
Incyte
INCY
$25.7B
$1.97M 0.05%
28,924
-11,979
-29% -$759K
RIGL icon
152
Rigel Pharmaceuticals
RIGL
$909M
$1.96M 0.05%
104,890
-5,494
-5% -$104K
OCUL icon
153
Ocular Therapeutix
OCUL
$2.34B
$1.95M 0.05%
210,205
-48,158
-19% -$377K
ADT icon
154
ADT
ADT
$5.45B
$1.94M 0.05%
229,607
– –
MGNI icon
155
CALL
Magnite
MGNI
$3.46B
$1.93M 0.05%
432,000
+325,000
+304% +$4.79M
MRVL icon
156
Marvell Technology
MRVL
$201B
$1.91M 0.05%
+24,688
New +$1.54M
AGIO icon
157
Agios Pharmaceuticals
AGIO
$1.98B
$1.89M 0.05%
56,810
-1,912
-3% -$58K
LOKV
158
DELISTED
Live Oak Acquisition Corp V
LOKV
$1.87M 0.05%
+174,923
New +$1.8M
CCJ icon
159
Cameco
CCJ
$43.9B
$1.86M 0.05%
+25,000
New +$1.33M
VRDN icon
160
Viridian Therapeutics
VRDN
$2.6B
$1.84M 0.05%
131,294
+24,206
+23% +$329K
IMCR icon
161
Immunocore
IMCR
$1.86B
$1.67M 0.05%
53,343
+8,147
+18% +$253K
CAT icon
162
Caterpillar
CAT
$374B
$1.63M 0.04%
+4,200
New +$1.4M
IQV icon
163
IQVIA
IQV
$44.1B
$1.62M 0.04%
10,275
+5,275
+106% +$794K
AACB
164
DELISTED
Artius II Acquisition Inc
AACB
$1.62M 0.04%
+160,000
New +$1.6M
POLE
165
Andretti Acquisition Corp II
POLE
$328M
$1.56M 0.04%
150,000
– –
TMO icon
166
Thermo Fisher Scientific
TMO
$227B
$1.53M 0.04%
+3,770
New +$1.58M
SOUL
167
Soulpower Acquisition Corp
SOUL
$1.51M 0.04%
+150,000
New +$1.5M
VIST icon
168
Vista Energy
VIST
$8.16B
$1.5M 0.04%
+31,391
New +$1.49M
GPRK icon
169
GeoPark
GPRK
$750M
$1.49M 0.04%
+228,367
New +$1.56M
WMT icon
170
Walmart Inc
WMT
$850B
$1.47M 0.04%
15,000
-15,000
-50% -$1.43M
PRCT icon
171
Procept Biorobotics
PRCT
$1.3B
$1.45M 0.04%
25,226
-2,774
-10% -$157K
KIDS icon
172
OrthoPediatrics
KIDS
$585M
$1.41M 0.04%
65,866
-8,996
-12% -$194K
HLT icon
173
Hilton Worldwide
HLT
$70B
$1.33M 0.04%
+5,000
New +$1.19M
ATEC icon
174
Alphatec Holdings
ATEC
$1.46B
$1.32M 0.04%
119,094
-75,143
-39% -$863K
AUTL
175
Autolus Therapeutics
AUTL
$596M
$1.29M 0.03%
+565,000
New +$934K
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2025 Portfolio in Review

As of Q2 2025, UBS O'Connor held 480 positions worth $3.69B, down 13% from $4.23B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor withdrew a net $781M in Q2 2025, closing 113 positions and reducing 86 holdings. Its most notable exit was Discover Financial Services, an estimated $408M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Skechers worth $227M.

  • UBS O'Connor's largest Q2 2025 buy was Skechers: 3,598,177 shares worth $227M.
  • UBS O'Connor added most to Blueprint Medicines in Q2 2025, an estimated $176M increase.
  • UBS O'Connor's biggest Q2 2025 reduction was Hess, cutting an estimated $251M.
  • UBS O'Connor fully exited Discover Financial Services in Q2 2025, selling an estimated $408M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.69B portfolio in Q2 2025.
  • UBS O'Connor opened 156 new positions and closed 113 in Q2 2025.
  • UBS O'Connor's portfolio value fell 13% quarter-over-quarter to $3.69B.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.